Fund Holdings — JOHNSON & JOHNSON

Total Portfolio Value:
$386.13M
Total Bought:
$526.9K
Total Sold:
$230.2K
Net Transaction:
+$296.7K
Securities
▲▼
SharesValue
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Protagonist Therapeutics Inc.2,449,1832,449,1830$110.21M$94.54M24.48%-$15.67M
CVRx, Inc.(CVRX)4,103,4304,103,4300$36.15M$51.99M13.46%+$15.84M
Rapport Therapeutics, Inc.(RAPP)2,498,0512,498,0510$51.16M$44.32M11.48%-$6.84M
MeiraGTx Holdings plc(MGTX)6,641,0646,641,0640$27.69M$40.44M10.47%+$12.75M
Contineum Therapeutics, Inc.CL A(CTNM)1,979,1731,979,1730$37.88M$28.99M7.51%-$8.89M
PROCEPT BioRobotics Corporation(PRCT)357,939357,9390$28.68M$28.82M7.46%+$143.2K
Legend Biotech CorporationADS(LEGN)814,586814,5860$39.69M$26.51M6.86%-$13.19M
Neumora Therapeutics, Inc.(NMRA)1,849,4451,849,4450$24.43M$19.60M5.08%-$4.83M
Xencor, Inc.(XNCR)748,062748,0620$15.04M$17.19M4.45%+$2.15M
Nanobiotix S.A.ADS(NBTX)5,623,8165,623,8160$32.34M$16.14M4.18%-$16.20M
Fate Therapeutics, Inc.(FATE)3,379,0643,379,0640$11.83M$5.58M1.44%-$6.25M
Arrowhead Pharmaceuticals, Inc.(ARWR)247,598247,5980$4.80M$4.65M1.21%-$141.1K
Rallybio Corporation(RLYB)3,636,3633,636,3630$4.25M$3.49M0.90%-$763.6K
Vor Biopharma Inc.(VOR)1,074,6581,074,6580$752.3K$1.19M0.31%+$440.6K
Nano-X Imaging Ltd.
ORD SHS
158,852158,8520$965.8K$1.14M0.30%+$177.9K
Standard BioTools Inc.(LAB)311,967311,9670$602.1K$545.9K0.14%-$56.2K
Lyell Immunopharma, Inc.(LYEL)0823,317+823,317$0$526.9K0.14%+$526.9K
Adicet Bio, Inc.364,472364,4720$524.8K$350.6K0.09%-$174.2K
Tessera Defense and Homeland Security Inc.(HLSQ)192,32196,866-95,455$196.2K$70.7K0.02%-$125.4K
Senseonics Holdings, Inc.(SENS)54,62154,6210$19.1K$28.6K0.01%+$9.5K
Clearside Biomedical, Inc.82,4810-82,481$104.8K$0—-$104.8K
Page 1 of 1